PBMI Report Shows Changes in Pharmacy Benefit Design to Meet Cost Challenges
PBMI Releases 2016 Trends in Drug Benefit Design Report
Plano, TX (Marketwired – December 12, 2016) ―Although employers continue to cite managing drug cost trend as the number one goal, they are addressing this challenge head on by implementing significant changes in drug benefit design. This is just a sampling of the results from PBMI’s 2016 Trends in Drug Benefit Design Report released today. The report includes responses from 337 benefit leaders representing employers with an estimated 12.3 million covered lives.
“As drug costs continue to rise, it’s no surprise that this year’s report shows employers maintain focusing their goals in the areas of managing specialty and overall drug benefit cost trend,” says Jane Lutz, Executive Director of PBMI. “As employers look to the future, collaboration to design more effective benefit designs is critical.”
The following are a few of the key findings from this year’s report:
- Employers are changing pharmacy benefit designs to manage cost increases
- Plans with four or more tiers continue to grow – 38% have four or more tiers, compared to only 26% in 2012
- Use of pharmacy deductibles are common and growing with 38% having a pharmacy deductible, either specific to the drug benefit or combined with the medial benefit
- Employers are also increasing use of incentives to encourage healthy behaviors
- Rewarding members who participate in health risk assessments increased by 12%
- Use of incentives to motivate behavior change rose 17%
- Reducing copayments for members who participate in care management programs increased 1%
- The report also identifies several opportunities
- 64% do not use preferred or limited retail networks
- 47% do not send member communications to encourage mail order or on-site pharmacy use
- Only 62% of employers reporting they currently have a program in place despite epidemic rates of substance abuse
“We hope our research continues to drive meaningful conversations and brings together all stakeholders involved in benefit design creation,” adds Lutz.
PBMI will host a free webinar on December 15 at 1:30 pm EST to showcase the report. Register today. To download or request a printed copy of this report click here.
About PBMI
The Pharmacy Benefit Management Institute provides research and education to help healthcare and benefits professionals work with pharmacy benefit managers to design prescription drug benefit programs. Learn more at www.pbmi.com.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.